R R

What Is Prevnar 20?

Prevnar 20 is a pneumococcal conjugate vaccine used to help prevent certain infections caused by Streptococcus pneumoniae bacteria. It contains components from 20 pneumococcal serotypes and is administered by intramuscular injection. Prevnar 20 is approved for individuals aged six weeks and older to prevent invasive pneumococcal disease caused by the covered serotypes. It also has age-specific indications for pneumococcal pneumonia and certain middle ear infections. Vaccination reduces the risk of disease caused by targeted bacteria but does not protect against every cause of pneumonia or ear infection.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Prevnar 20?

Prevnar 20 is a pneumococcal conjugate vaccine used to help prevent certain infections caused by Streptococcus pneumoniae bacteria. It contains components from 20 pneumococcal serotypes and is administered by intramuscular injection. Prevnar 20 is approved for individuals aged six weeks and older to prevent invasive pneumococcal disease caused by the covered serotypes. It also has age-specific indications for pneumococcal pneumonia and certain middle ear infections. Vaccination reduces the risk of disease caused by targeted bacteria but does not protect against every cause of pneumonia or ear infection.

read more about prevnar 20 ...

Copy this HTML:

Copy HTML Copied!

How Does Prevnar 20 Work?

Prevnar 20 contains purified capsular polysaccharides from 20 Streptococcus pneumoniae serotypes linked to a carrier protein derived from diphtheria toxin. This conjugation helps the immune system recognize the bacterial components and develop antibodies against them. When a vaccinated person encounters a covered pneumococcal serotype, the immune response can help prevent infection from progressing to disease. Prevnar 20 does not contain live pneumococcal bacteria and cannot cause pneumococcal infection. Protection develops after vaccination and varies with age, immune function, and previous vaccination history.

What Diseases Does Prevnar 20 Help Prevent?

Prevnar 20 is approved to prevent invasive pneumococcal disease caused by 20 specified serotypes in individuals aged six weeks and older. Invasive disease can include bloodstream infections and meningitis. The vaccine is also approved to prevent pneumonia caused by the covered serotypes in adults aged 18 years and older. For children aged six weeks through five years, it has an additional indication for preventing otitis media caused by seven specified serotypes. Prevnar 20 does not treat active infections or protect against all pneumococcal strains. Vaccination recommendations depend on age, medical risk factors, and previous pneumococcal vaccines.

How Is Prevnar 20 Administered?

Prevnar 20 is administered as a 0.5 mL intramuscular injection by a healthcare professional. Infants beginning the routine series at two months generally receive doses at two, four, six, and 12 through 15 months of age. Children receiving catch-up vaccination follow schedules based on age and previous pneumococcal vaccine doses. Adults generally receive a single dose when indicated, although the appropriate schedule depends on prior vaccination history and current immunization recommendations. The vaccine is injected into an age-appropriate muscle. Healthcare professionals review allergies, previous vaccines, and relevant medical conditions before administration.

What Are the Side Effects and Warnings of Prevnar 20?

Common adverse reactions include injection-site pain, redness, swelling, fatigue, headache, muscle pain, and joint pain. Infants and children may also experience irritability, sleepiness, and reduced appetite. Serious allergic reactions, including anaphylaxis, can occur. Prevnar 20 should not be administered to individuals with a history of severe allergic reactions to its ingredients or diphtheria toxoid. Premature infants may require consideration of apnea risk following vaccination. People with weakened immune systems may have a reduced response. Breathing difficulties, facial swelling, or other symptoms of a severe allergic reaction require immediate medical attention.

Common Questions About Prevnar 20

Is Prevnar 20 a pneumonia vaccine?

Yes. Prevnar 20 is a pneumococcal conjugate vaccine that helps prevent disease caused by 20 pneumococcal serotypes. Its pneumonia indication applies to adults aged 18 years and older.

Can children receive Prevnar 20?

Yes. Prevnar 20 is approved for individuals aged six weeks and older. Pediatric dosing schedules depend on age and previous vaccination history.

Does Prevnar 20 protect against all pneumonia?

No. Prevnar 20 targets specified Streptococcus pneumoniae serotypes. Pneumonia caused by other bacteria, viruses, or organisms can still occur.

Is Prevnar 20 a live vaccine?

No. Prevnar 20 is a conjugate vaccine containing purified bacterial components linked to a carrier protein. It does not contain live pneumococcal bacteria.

References

DailyMed - PREVNAR 20 (pneumococcal 20-valent conjugate vaccine) injection, suspension. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4e2cf51-e6a8-4103-bb1d-6120c6474ff8. Date Accessed November 2, 2026.

Pneumococcal Conjugate Vaccine. MedlinePlus. https://medlineplus.gov/druginfo/meds/a610017.html. Date Accessed November 2, 2026.

Pneumococcal Vaccination: Information for Health Care Providers. Centers for Disease Control and Prevention. https://www.cdc.gov/vaccines/hcp/by-disease/pneumo.html. Date Accessed November 2, 2026.

PREVNAR 20. U.S. Food and Drug Administration. https://www.fda.gov/vaccines-blood-biologics/vaccines/prevnar-20. Date Accessed November 2, 2026.

Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine). Pfizer. https://www.pfizer.com/products/product-detail/prevnar-20tm. Date Accessed November 2, 2026.